Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
Poster available until
  • x Monday 29 June 2026 (373)
  • Tuesday 15 December 2026 (1)
  • Until platform closure (793)
Poster categories
  • e-Thematic Poster Session (37)
  • Thematic Poster Session (336)
keywords
Session Reference
  • L-TPS01 (2)
  • L-TPS02 (1)
  • L-TPS03 (5)
  • L-TPS04 (1)
  • L-TPS06 (1)
  • L-TPS07 (6)
  • L-TPS08 (2)
  • L-TPS09 (3)
  • L-TPS10 (4)
  • L-TPS11 (5)
  • L-TPS12 (2)
  • L-TPS13 (4)
  • L-TPS14 (1)
  • L-TPS15 (2)
  • L-TPS16 (2)
  • L-TPS17 (4)
  • L-TPS18 (4)
  • L-TPS20 (2)
  • L-TPS22 (1)
  • L-TPS23 (1)
  • L-TPS24 (4)
  • L-TPS25 (3)
  • TPS01 (5)
  • TPS02 (2)
  • TPS03 (4)
  • TPS04 (6)
  • TPS05 (3)
  • TPS06 (4)
  • TPS07 (3)
  • TPS08 (3)
  • TPS09 (2)
  • TPS10 (6)
  • TPS11 (7)
  • TPS12 (6)
  • TPS13 (1)
  • TPS14 (6)
  • TPS15 (5)
  • TPS16 (3)
  • TPS17 (4)
  • TPS18 (2)
  • TPS20 (5)
  • TPS21 (4)
  • TPS22 (4)
  • TPS23 (3)
  • TPS24 (4)
  • TPS25 (3)
  • TPS26 (7)
  • TPS29 (1)
  • TPS30 (2)
  • TPS31 (5)
  • TPS33 (2)
  • TPS34 (5)
  • TPS35 (4)
  • TPS36 (3)
  • TPS37 (2)
  • TPS38 (4)
  • TPS39 (3)
  • TPS40 (6)
  • TPS41 (4)
  • TPS42 (3)
  • TPS43 (3)
  • TPS44 (3)
  • TPS45 (1)
  • TPS46 (1)
  • TPS47 (3)
  • TPS48 (1)
  • TPS49 (1)
  • TPS50 (4)
  • TPS51 (6)
  • TPS52 (6)
  • TPS53 (6)
  • TPS54 (3)
  • TPS55 (6)
  • TPS56 (3)
  • TPS57 (1)
  • TPS60 (3)
  • TPS61 (5)
  • TPS62 (3)
  • TPS63 (2)
  • TPS64 (3)
  • TPS65 (1)
  • TPS66 (6)
  • TPS67 (3)
  • TPS68 (6)
  • TPS69 (1)
  • TPS70 (1)
  • TPS71 (1)
  • TPS72 (2)
  • TPS73 (3)
  • TPS74 (2)
  • TPS75 (6)
  • TPS76 (1)
  • TPS77 (1)
  • TPS78 (2)
  • TPS79 (11)
  • TPS80 (3)
  • TPS82 (7)
  • TPS83 (2)
  • TPS84 (4)
  • TPS85 (3)
  • TPS86 (1)
373 results
Thumbnail

D2.489 - B-Cell Subset Reconstitution After Rituximab-Containing Chemotherapy in Children and Adolescents With Non-Hodgkin Lymphoma: A Single-Center Experience

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study

Thumbnail

D2.499 - Immunoregulatory Effects of Dupilumab Added to Omalizumab-Facilitated Multi-Allergen Oral Immunotherapy in the COMBINE clinical trial

Thumbnail

D2.504 - Novel food supplement containing a combination of bioactive compounds in pediatric cow’s milk protein allergy: results from a randomized, placebo-controlled trial

Thumbnail

D2.505 - Sustainable Allergy Management: a Task force report

Thumbnail

D2.516 - Can social media track seasonal allergy burden? An evidence-weighted geo-location pipeline and validation against airborne pollen exposure in Augsburg, Germany

Thumbnail

D2.524 - How much does wheat oral immunotherapy improve quality of life?

Thumbnail

D2.530 - Digital patient-reported data uncover key clinical features of mastocytosis: insights from the MASTHAVE App

Thumbnail

D2.60 - Beyond the Barrier: Does Atopic Dermatitis Shape Patch Test Reactivity? – A Romanian Retrospective Study

Thumbnail

D2.73 - Secondary Domestic Exposure to Colophony as a Cause of Allergic Contact Dermatitis: A Case Report

Thumbnail

D2.90 - Potato Allergy in Children: Clinical Features, Laboratory Findings, and Tolerance Development

Thumbnail

D2.91 - Exploring Geographic Differences in Ragweed and Mugwort Hypersensitivity Among Patients with Respiratory Symptoms of Allergy in Eastern and Western Europe

Thumbnail

D3.100 - Assessment of the impact of psychotropic drugs, antihistamines, and corticosteroids on the interpretation of skin tests in allergology

Thumbnail

D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report

Thumbnail

D3.221 - Cat Immunotherapy and Real-Life Data: A Single-Center Experience

Thumbnail

D3.27 - Nivolumab-Induced Psoriasiform Eruption: Diagnostic Challenge Between Immune-Related Toxicity and Drug Allergy

Thumbnail

D3.298 - The Good, the Bad and the Ugly : Mugwort, Mango, and Pineapple

Thumbnail

D3.306 - Veno-Venous ECMO For Aprotinin-Induced Perioperative Anaphylaxis

Thumbnail

D3.314 - Rapid desensitization to intravenous risankizumab after anaphylaxis in a patient with Crohn’s disease: a case report

Thumbnail

D3.315 - Management of Drug Hypersensitivity Reactions in an Oncology Patient: An Atypical Case of Omeprazole Allergy with Pantoprazole Tolerance

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2026 EAACI
Made with   by CYIM